ON BODY DELIVERY SYSTEMS.
We are ready when you are.

Our OBDS platform is more than ready – it is commercialised and helping patients around the world. Today.

The UDENYCA On-body injector utilising our technology platform has taken the market by storm, not least because of its ability to deliver treatment in 5 mins compared to the 45 mins it takes its competitor device to deliver the same dose.

Our entirely customizable platform supports a wide range of dose volumes and dosing regimens, allowing pharma partners to tailor their device according to patient need.

The point-of-care loaded configuration delivers volumes up to 2mL while a larger configuration can be pre-filled and pre-loaded to accommodate between 5mL and 50mL.

Both iterations are compatible with standard vials (6R, 8R, 15R, 20R and 25R) and proprietary cartridges (5ml, 10ml, 15ml and 20ml).

All in all, we will support you in ensuring your product is in the clinic within 9 months of project initiation.

Key benefits for pharmaceutical partners

Frau mit OBDS am Bauch

  • Platform design reduces development time and cost, while enabling customer flexibility in development – from project initiation to clinic in just nine months.

  • Connectivity function to deliver product improvement and compliance data

  • Wide range of volumes available from 1mL to 50+ mL

  • Primary-container agnostic to fits seamlessly into established filling processes

  • Software-controlled for unlimited infusion profiles

  • Novel UV disinfection at point-of-care simplifies loading of primary container

  • Electromechanical ‘pulling’ of drug protects sensitive biologics

Key benefits for patients

  • Designed to optimise patient experience and improve regimen adherence

  • Pre-filled and pre-loaded to make use easier for the user, simply peel, stick, initiate

  • No patient handling of needles nor drug

  • Reassurance in successful and safe administration enabled by tactile, audio, and visual smart indicators

  • Virtually-painless needle deployment for enhanced user-experience

  • Automating management of drug regimen

  • Greater convenience: potential for home-based self-care

  • Supply of larger drug volumes

  • Avoiding or reducing time in clinic